共 26 条
- [14] Bendamustine-Bortezomib-Dexamethasone (BVD) in Heavily Pre-Treated Multiple Myeloma: Old/New in the Novel Agents' Era CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S442 - S442
- [19] Impact of Daratumumab/Bortezomib/Thalidomide/Dexamethasone (DVTD) Induction Therapy on Chemo-Free Stem Cell Mobilization in Newly Diagnosed Multiple Myeloma Patients: A Real Life Experience CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S241 - S241